** Shares of BSF Enterprise BSFAB.L rise as much as 11.3%
to 17.25p, stock among top pct gainers across all London bourses
** Biotechnology investment firm says unit 3D Bio Tissues
(3DBT) has secured its first customer in relation to its
City-Mix product
** City-Mix is a non-toxic cell-booster supplement,
according to 3DBT's website
** BSF Enterprise says two other cos also completed
successful evaluations, expected to begin buying product in
April 2023
** Adds it has doubled its lab production space and
validated City-Mix production and quality control processes
** Including session's gains, stock up ~2% this year
(Reporting by Prerna Bedi in Bengaluru)
((Prerna.Bedi@thomsonreuters.com; +91 98052 24616;))